Biotechnology

116 articles in this category (Page 3 of 5)

Stock Weather AIBiotechnologyGrowth Stocks

Apellis Pharmaceuticals – 2026-01-12 - increase Confidence 8/10

Strong revenue growth and improving losses meet high analyst upside expectations, signaling near-term price momentum for APLS.

Jan 12, 2026APLS

Stock Weather AIBiotechnologyClinical Stage Biotech

Beam Therapeutics – 2026-01-12 - Increase Confidence 8/10

Negative free cash flow offset by $1.25B cash runway and FDA breakthroughs; BEAM-302 & risto-cel catalysts drive near-term upside.

Jan 12, 2026BEAM

Stock Weather AIBiotechnologyClinical Trials

Summit Therapeutics Inc. – 2026-01-12 - increase Confidence 7/10

Negative free cash flow and high leverage are outweighed by strong analyst momentum and Phase III trial expansion, signaling near-term upside.

Jan 12, 2026SMMT

Stock Weather AIBiotechnologyClinical Trials

CG Oncology – 2026-01-09 - Increase Confidence 8/10

Strong cash position and recent positive trial data converge with upcoming J.P. Morgan Conference presentation to catalyze near-term upside.

Jan 9, 2026CGON

Stock Weather AIBiotechnologyHealthcare

Madrigal Pharmaceuticals – 2026-01-09 - Increase Confidence 8/10

Strong revenue growth and recent positive catalysts signal near-term upside despite negative free cash flow.

Jan 9, 2026MDGL

Stock Weather AIBiotechnologyM&A Speculation

NovaBay Pharmaceuticals – 2026-01-09 - increase Confidence 6/10

Negative free cash flow contrasts with potential acquisition catalyst, driving short-term upside in speculative momentum.

Jan 9, 2026NBY

Stock Weather AIBiotechnologyClinical-Stage Stocks

Wave Life Sciences – 2026-01-09 - Increase Confidence 7/10

Negative free cash flow and high debt are offset by strong upcoming catalysts and recent positive trial data, pointing to near-term upside.

Jan 9, 2026WVE

Stock Weather AIBiotechnologyClinical-Stage Pharma

Crinetics Pharmaceuticals – 2026-01-07 - Increase Confidence 7/10

Negative free cash flow and high debt are offset by imminent clinical data readouts and bullish analyst targets, creating near-term catalyst-driven upside potential.

Jan 7, 2026CRNX

Stock Weather AIBiotechnologyClinical-Stage Pharma

Revolution Medicines – 2026-01-07 - increase Confidence 8/10

Strong cash runway and positive trial data for RMC-6236 in pancreatic cancer signal near-term upside despite negative free cash flow.

Jan 7, 2026RVMD

Stock Weather AIBiotechnologyEarnings Catalyst

Liquidia Corporation – 2026-01-02 - increase Confidence 8/10

Profitability achieved in Q3 2025 alongside strong YUTREPIA adoption, with analyst targets implying 40% upside, signals near-term price appreciation.

Jan 2, 2026LQDA

Stock Weather AIBiotechnologyGrowth Stocks

Axsome Therapeutics – 2026-01-01 - Increase Confidence 8/10

Strong revenue growth and imminent NDA submission for AXS-12, combined with recent FDA momentum, signal near-term upside.

Jan 1, 2026AXSM

Stock Weather AIBiotechnologyEarnings Momentum

Corcept Therapeutics – 2026-01-01 - Increase Confidence 7/10

Strong revenue growth and insider option exercises signal confidence, while key clinical data readouts loom—stock poised for near-term upside.

Jan 1, 2026CORT

Stock Weather AIBiotechnologyGrowth Stocks

Axsome Therapeutics – 2025-12-31 - Increase Confidence 7/10

Strong revenue beat and late-stage pipeline momentum outweigh negative cash flow, with next earnings catalyst approaching.

Dec 31, 2025AXSM

Stock Weather AIBiotechnologyEarnings Catalyst

Corcept Therapeutics – 2025-12-31 - Increase Confidence 8/10

Strong free cash flow and gross margin paired with imminent NDA submission for relacorilant drive upside potential in the near term.

Dec 31, 2025CORT

Stock Weather AIBiotechnologyClinical Trials

Corcept Therapeutics – 2025-12-30 - Increase Confidence 8/10

Strong free cash flow and recent FDA acceptance of relacorilant for ovarian cancer signal near-term upside despite high valuation.

Dec 30, 2025CORT

Stock Weather AIBiotechnologyClinical Trials

Ultragenyx Pharmaceutical – 2025-12-30 - Decrease Confidence 8/10

Negative free cash flow and sky-high debt/equity meet Phase III trial failure; stock poised to decrease despite short-term rally.

Dec 30, 2025RARE

Stock Weather AIBiotechnologyClinical Trials

Belite Bio – 2025-12-29 - Increase Confidence 8/10

Strong cash position and recent positive Phase 3 trial results act as catalysts for near-term upside despite ongoing negative free cash flow.

Dec 29, 2025BLTE

Stock Weather AIBiotechnologyMomentum Investing

Praxis Precision Medicines – 2025-12-29 - Increase Confidence 8/10

Negative free cash flow contrasts with FDA breakthrough designation for ulixacaltamide, triggering momentum surge and near-term upside potential.

Dec 29, 2025PRAX

Stock Weather AIBiotechnologyClinical Trials

Edgewise Therapeutics – 2025-12-25 - Increase Confidence 8/10

Negative free cash flow contrasts with positive Phase 2 trial data for EDG-7500, triggering investor optimism and a near-term price catalyst for EWTX.

Dec 25, 2025EWTX

Stock Weather AIBiotechnologyEarnings Momentum

Travere Therapeutics – 2025-12-25 - Increase Confidence 8/10

Strong revenue growth and recent profitability shift, combined with bullish analyst momentum and upcoming FDA catalyst, signal near-term upside.

Dec 25, 2025TVTX

Stock Weather AIBiotechnologyAnalyst Sentiment

Edgewise Therapeutics Inc. – 2025-12-24 - Increase Confidence 8/10

Negative free cash flow offset by strong analyst momentum and recent upgrades, signaling near-term upside driven by clinical pipeline anticipation.

Dec 24, 2025EWTX

Stock Weather AIBiotechnologyClinical Trials

Structure Therapeutics – 2025-12-23 - increase Confidence 8/10

Strong cash reserves and recent positive Phase 2 trial data for its oral weight loss drug aleniglipron signal near-term upside despite negative free cash flow.

Dec 23, 2025GPCR

Stock Weather AIBiotechnologyHealthcare

Moderna – 2025-12-23 - increase Confidence 6/10

Negative gross margin and high leverage offset by new vaccine trial breakthroughs and seasonal demand tailwinds, pointing to near-term upside.

Dec 23, 2025MRNA

Stock Weather AIBiotechnologyClinical-Stage Pharma

ABIVAX – 2025-12-22 - Increase Confidence 6/10

Strong Buy consensus and late-stage clinical catalysts outweigh negative cash flow, with near-term upside likely on ulcerative colitis Phase 3 readout anticipation.

Dec 22, 2025ABVX